Code · BILL · 116th Congress · S. 2740 (Reported in Senate) — To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonpres... · Sec. 1

Sec. 1. Short title; table of contents

108 words·~1 min read·/bill/116/s/2740/rs/section-1

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

This Act may be cited as the . Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. TITLE I—OTC Drug Review Sec. 101. Regulation of certain nonprescription drugs that are marketed without an approved drug application. Sec. 102. Misbranding. Sec. 103. Drugs excluded from the over-the-counter drug review. Sec. 104. Treatment of Sunscreen Innovation Act. Sec. 105. Annual update to Congress on appropriate pediatric indication for certain OTC cough and cold drugs.

Sec. 106. Technical corrections. TITLE II—User Fees Sec. 201. Short title; finding. Sec. 202. Fees relating to over-the-counter drugs.